Impact of Pharmacist Counseling on Health-related Quality of Life of Patients with Type 2 Diabetes Mellitus: a Cluster Randomized Controlled Study

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2021 Feb 1

PMID 33520795

Citations 2

Authors

Fajriansyah

Aulia Iskandarsyah

Irma M Puspitasari

Keri Lestari

Affiliations

Soon will be listed here.

Abstract

Purpose: The quality of life (QoL) of patients with type 2 diabetes mellitus (T2DM) is a measure of the successful outcomes of therapy. The program of management of chronic diseases "Program Pengelolaan Penyakit Kronis" (Prolanis) among patients with hypertension and T2DM is a new strategy of the Badan Penyelenggara Jaminan Sosial (BPJS), which is the Indonesian national health insurance system. Here, we analyzed the impact of pharmacist counseling interventions on health-related QoL (HRQoL) in Prolanis T2DM patients.

Methods: This cluster randomized controlled trial was designed to include two groups [control ( = 111) and intervention ( = 109) groups], and pre- and post-test procedures. The participants were Prolanis T2DM patients who attended four primary health-care centers (Puskesmas) in Makassar City, South Sulawesi, Indonesia from August 2017 to August 2018. The intervention group received systematic counseling for 6 months. The data were collected using the Bahasa Indonesia version of the European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5 L) questionnaire and were analyzed using EQ-5D preference weight for each health state with the Indonesian EQ-5D-5 L value Set. Furthermore, the EQ-5D index and the EQ-5D VAS score were calculated and HbA1c levels were assessed.

Results: The change in the EQ-5D-5 L index score (post-pre) was 0.01 in the control group and 0.04 in the intervention group ( = 0.041). The change in the VAS score was -0.07in the control group (post-pre) and 2.66 in the intervention group ( = 0.000).

Conclusion: Pharmacist counseling may help improve the HRQoL of Prolanis T2DM patients.

Citing Articles

Expanding access to NCD services via community retail pharmacies in LMICs: a systematic review of the literature.

Gentilini A, Kasonde L, Babar Z J Pharm Policy Pract. 2025; 18(1):2462450.

PMID: 39968320 PMC: 11834798. DOI: 10.1080/20523211.2025.2462450.

Hypertension in Adults With Diabetes in Southeast Asia: A Systematic Review.

Wong W, Van Nguyen T, Ahmad F, Vu H, Koh A, Tan K J Clin Hypertens (Greenwich). 2024; 27(1):e14936.

PMID: 39545715 PMC: 11771803. DOI: 10.1111/jch.14936.

Patient-pharmacist relationship dynamics: a mediation analysis of patient characteristics and reported outcomes.

Sacre H, Haddad C, Sakr F, Safwan J, Hajj A, Zeenny R J Pharm Policy Pract. 2024; 17(1):2371409.

PMID: 39015753 PMC: 11251441. DOI: 10.1080/20523211.2024.2371409.

Impact of Pharmacists-Led Interventions in Primary Care for Adults with Type 2 Diabetes on HbA1c Levels: A Systematic Review and Meta-Analysis.

Coutureau C, Slimano F, Mongaret C, Kanagaratnam L Int J Environ Res Public Health. 2022; 19(6).

PMID: 35328842 PMC: 8949021. DOI: 10.3390/ijerph19063156.

References

Nitin S . HbA1c and factors other than diabetes mellitus affecting it. Singapore Med J. 2010; 51(8):616-22. View

Johari N, Manaf Z, Ibrahim N, Shahar S, Mustafa N . Predictors of quality of life among hospitalized geriatric patients with diabetes mellitus upon discharge. Clin Interv Aging. 2016; 11:1455-1461. PMC: 5074738. DOI: 10.2147/CIA.S105652. View

Megari K . Quality of Life in Chronic Disease Patients. Health Psychol Res. 2016; 1(3):e27. PMC: 4768563. DOI: 10.4081/hpr.2013.e27. View

Steinsbekk A, Rygg L, Lisulo M, Rise M, Fretheim A . Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012; 12:213. PMC: 3418213. DOI: 10.1186/1472-6963-12-213. View

Johnson C, Nicholas A, Divine H, Perrier D, Blumenschein K, Steinke D . Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc (2003). 2008; 48(6):722-30. DOI: 10.1331/JAPhA.2008.07133. View

Quinn C, Royak-Schaler R, Lender D, Steinle N, Gadalla S, Zhan M . Patient understanding of diabetes self-management: participatory decision-making in diabetes care. J Diabetes Sci Technol. 2011; 5(3):723-30. PMC: 3192639. DOI: 10.1177/193229681100500327. View

Purba F, Hunfeld J, Iskandarsyah A, Fitriana T, Sadarjoen S, Ramos-Goni J . The Indonesian EQ-5D-5L Value Set. Pharmacoeconomics. 2017; 35(11):1153-1165. PMC: 5656740. DOI: 10.1007/s40273-017-0538-9. View

Agborsangaya C, Lau D, Lahtinen M, Cooke T, Johnson J . Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual Life Res. 2012; 22(4):791-9. DOI: 10.1007/s11136-012-0214-7. View

Odegard P, Goo A, Hummel J, Williams K, Gray S . Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005; 39(3):433-40. DOI: 10.1345/aph.1E438. View

10.

Nichols G, Rosales A, Kimes T, Tunceli K, Kurtyka K, Mavros P . The Change in HbA1c Associated with Initial Adherence and Subsequent Change in Adherence among Diabetes Patients Newly Initiating Metformin Therapy. J Diabetes Res. 2016; 2016:9687815. PMC: 4992509. DOI: 10.1155/2016/9687815. View

11.

Bannier K, Lichtenauer M, Franz M, Fritzenwanger M, Kabisch B, Figulla H . Impact of diabetes mellitus and its complications: survival and quality-of-life in critically ill patients. J Diabetes Complications. 2015; 29(8):1130-5. DOI: 10.1016/j.jdiacomp.2015.08.010. View

12.

Clifford R, Davis W, Batty K, Davis T . Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005; 28(4):771-6. DOI: 10.2337/diacare.28.4.771. View

13.

Palaian S, Prabhu M, Ravi Shankar P . Patient counseling by pharmacist - a focus on chronic illness. Pak J Pharm Sci. 2006; 19(1):65-72. View

14.

Scott D, Boyd S, Stephan M, Augustine S, Reardon T . Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006; 63(21):2116-22. DOI: 10.2146/ajhp060040. View

15.

van Eikenhorst L, Taxis K, van Dijk L, de Gier H . Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis. Front Pharmacol. 2018; 8:891. PMC: 5735079. DOI: 10.3389/fphar.2017.00891. View

16.

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View

17.

Kjeldsen L, Bjerrum L, Dam P, Larsen B, Rossing C, Sondergaard B . Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies. Res Social Adm Pharm. 2014; 11(1):47-62. DOI: 10.1016/j.sapharm.2014.03.003. View

18.

Gusmai L, Novato T, de Souza Nogueira L . [The influence of quality of life in treatment adherence of diabetic patients: a systematic review]. Rev Esc Enferm USP. 2015; 49(5):839-46. DOI: 10.1590/S0080-623420150000500019. View